|1.||Monge, Luis: 3 articles (01/2014 - 06/2011)|
|2.||Fernández, Nuria: 3 articles (01/2014 - 06/2011)|
|3.||Carreño-Tarragona, Gonzalo: 2 articles (01/2014 - 08/2012)|
|4.||Granado, Miriam: 2 articles (01/2014 - 08/2012)|
|5.||Diéguez, Godofredo: 2 articles (08/2012 - 06/2011)|
|6.||García-Villalón, Angel Luis: 2 articles (08/2012 - 06/2011)|
|7.||Kamei, Junzo: 2 articles (10/2006 - 12/2005)|
|8.||Takahashi, Yoshiki: 2 articles (10/2006 - 12/2005)|
|9.||Amor, Sara: 1 article (01/2014)|
|10.||García-Villalón, Ángel Luis: 1 article (01/2014)|
|1.||Prostatic Neoplasms (Prostate Cancer)
09/01/2007 - "We also report the loss of a clinically established prostate cancer serum biomarker, prostate-specific antigen (PSA), after albumin is eliminated using two commercially available albumin elimination kits: one that uses Cibacron Blue F3GA, which achieves albumin depletion through dye-ligand binding, and one that uses specific albumin antibody. "
07/01/2006 - "Reactive Blue 2 improved sensorimotor deficit and restricted the volume of infarction, without preventing the expression of P2X7, but inducing it in the microglia of contralateral frontal and parietal cortex and striatum, which had lost reciprocal connections with the remote infarct area. "
|3.||Wounds and Injuries (Trauma)
12/15/2004 - "Additional studies demonstrated that wound closure was inhibited by reactive blue 2. These results indicate that P2Y receptors play a critical role in the injury repair process."
03/01/2007 - "The purinoceptor antagonist reactive blue 2 decreased wound closure and attenuated ATP-gamma-S induced HB-EGF shedding. "
|4.||Hepatocellular Carcinoma (Hepatoma)
02/28/1983 - "Taking advantage of the variant alkaline phosphatase from human hepatocellular cancer tissue to behave on the dye adsorbent in a similar fashion with the intestinal enzyme, it was purified by Cibacron Blue F3GA affinity chromatography, producing a 189-fold purification with a yield of 93%."
02/28/1983 - "Interaction of human intestinal and hepatoma alkaline phosphatases with immobilized Cibacron Blue F3GA."
01/01/1983 - "Separation and quantitation of hepatoma-associated gamma-glutamyltransferase by affinity chromatography with Affi-Gel blue and Con A-Sepharose."
10/15/1996 - "In HTC rat hepatoma cells, swelling induced by hypotonic exposure increased membrane Cl- current density to 44.8 +/- 7.1 pA/pF at -80 mV. Both the rate of volume recovery and the increase in Cl- permeability were inhibited in the presence of the ATP hydrolase apyrase (3 units/ml) or by exposure to the P2 receptor blockers suramin and Reactive Blue 2 (10-100 microM). "
01/01/1983 - "Isozymes of serum gamma-glutamyltransferase (GGT) in patients with hepatocellular carcinoma (HCC) and other liver diseases were separated into two groups by double-affinity column chromatography with Affi-Gel blue and Con A-Sepharose, one recovered in the unbound fraction and the other in the bound fraction. "
|5.||Whooping Cough (Pertussis)
01/01/2007 - "pertussis cells (strain 165) by heating for 1 h at 60 degrees C, followed by DEAE-Sepharose and Affi-Gel Blue chromatography. "
02/01/1990 - "pertussis cells for 1 h at 60 degrees C followed by DEAE-Sepharose and Affi-Gel Blue chromatography. "
07/01/1988 - "pertussis in a simple, defined medium to obtain a PT-rich supernatant with little contamination of cellular antigens; (ii) a simple, one-step concentration of PT in the culture supernatant with Affi-Gel Blue (Bio-Rad Laboratories, Richmond, Calif.); and (iii) specific adsorption of PT as the test antigen to microtiter wells coated with fetuin for the enzyme-linked immunosorbent assay. "
|1.||Prostate-Specific Antigen (Semenogelase)
|3.||Adenosine Triphosphate (ATP)
|4.||Suramin (Suramin Sodium)
|6.||NG-Nitroarginine Methyl Ester (L-NAME)
|7.||Purinergic Receptors (Receptors, Purine)
|9.||Citric Acid (Citrate)
|10.||Nitric Oxide (Nitrogen Monoxide)